Emcure Pharmaceuticals Limited (NSE:EMCURE)

Emcure Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 13, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	257,997	203,202	-	-	-	-
Enterprise Value	267,764	214,615	-	-	-	-
Last Close Price	1361.40	1072.40	-	-	-	-
PE Ratio	37.37	29.82	-	-	-	-
Forward PE	27.59	24.17	-	-	-	-
PS Ratio	3.27	2.57	-	-	-	-
PB Ratio	5.56	4.38	-	-	-	-
P/TBV Ratio	7.37	5.81	-	-	-	-
P/FCF Ratio	40.96	32.26	-	-	-	-
P/OCF Ratio	30.29	23.86	-	-	-	-
PEG Ratio	1.06	0.93	-	-	-	-
EV/Sales Ratio	3.39	2.72	-	-	-	-
EV/EBITDA Ratio	18.23	14.61	-	-	-	-
EV/EBIT Ratio	24.68	19.79	-	-	-	-
EV/FCF Ratio	42.51	34.07	-	-	-	-
Debt / Equity Ratio	0.22	0.22	0.75	0.88	1.05	1.04
Debt / EBITDA Ratio	0.70	0.70	1.91	1.99	1.68	1.93
Debt / FCF Ratio	1.62	1.62	2.84	6.55	5.69	4.26
Asset Turnover	0.99	0.99	0.92	0.94	0.91	0.79
Inventory Turnover	1.79	1.79	1.66	1.54	1.47	1.39
Quick Ratio	0.86	0.86	0.75	0.72	0.51	0.58
Current Ratio	1.71	1.71	1.33	1.27	1.16	1.09
Return on Equity (ROE)	18.23%	18.23%	18.28%	23.59%	31.35%	27.90%
Return on Assets (ROA)	8.45%	8.45%	7.92%	9.04%	10.54%	9.43%
Return on Capital (ROIC)	12.19%	12.19%	10.98%	12.36%	14.80%	13.20%
Return on Capital Employed (ROCE)	19.50%	19.50%	20.00%	25.20%	35.00%	28.40%
Earnings Yield	2.64%	3.35%	-	-	-	-
FCF Yield	2.44%	3.10%	-	-	-	-
Dividend Yield	0.22%	0.28%	-	-	-	-
Payout Ratio	-	-	10.89%	6.80%	8.19%	4.61%
Buyback Yield / Dilution	-3.40%	-3.40%	-0.01%	-	-	-
Total Shareholder Return	-3.18%	-3.12%	-0.01%	-	-	-

Updated Feb 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.